Back
35· Cooling
Technology4h 6m ago
Researchers identified underlying molecular mechanisms of platinum resistance in triple-negative breast cancers with TP53 mutations and LIG1 gene loss, and used combinations of available drugs to reduce tumor growth in animal models.
Archive Window: 7 Days Left
Baylor College of Medicine
Who
researchers at Baylor College of Medicine and collaborating institutions
What
Researchers identified underlying molecular mechanisms of platinum resistance in triple-negative breast cancers with TP53 mutations and LIG1 gene loss, and used combinations of available drugs to reduce tumor growth in animal models.
When
Sat, 18 Jul 2026 00:40:01 GMT · 4h 6m ago
Where
Baylor College of Medicine ·
Why
Loss of one copy of the DNA ligase I (LIG1) gene in triple-negative breast cancers (TNBC) with TP53 mutations confers resistance to chemotherapy.
The Frontline Impact
How this affects you
This research identified a therapeutic vulnerability in certain triple-negative breast cancers, potentially leading to new treatment strategies and patient stratification for clinical trials.
Story chain
1 event in this threadNo related history yet - this is the origin event.